Skip to main content

Table 3 The questionnaire for feasibility assessment

From: Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

Sample size

Special care ward

  

Daily Enter

5

 

Daily Discharge/Death

3

 

Total Capacity

15

 

Data access

Demographic information

Hardcopy of patient file

Local access to HIS of hospital

Remote access to HIS of hospital

Full access to patients's information after discharge

Accessable options

10 + 

10 + 

10 + 

0

5 + 

Access to cause of death

No information

General information

Professional information

Aceccable Options

0

3 + 

2 + 

  1. HIS Health information System